![]() |
|
|
Vol. 289, Issue 3, 1185-1190, June 1999
Divisions of Plastic and Reconstructive (M.V.S., X.R., C.M.,
J.H.B.), General (J.W.J.), and Hand and Microsurgery (W.C.B.),
Department of Surgery, Effective antirejection therapy with minimal systemic morbidity is
required if limb transplantation is to become a clinical reality. We
investigated whether i.a. infusion of cyclosporin A (CSA) into the
vascularly isolated rabbit forelimb will distribute drug homogeneously
to the tissues and produce higher local drug levels than same-dose i.v.
treatment, thereby improving the therapeutic index. CSA 4.0 mg/kg/day
was infused continuously via osmotic minipump into either the right
brachial artery (i.a. group) or jugular vein (i.v. group) of New
Zealand rabbits. Ligation of all muscles at the right mid-arm level was
performed in the i.a. group to eliminate collateral circulation and
simulate allografting, while leaving bone and neurovasculature intact.
On day 6, CSA concentrations were measured in skin, muscle, bone, and
bone marrow samples taken from different compartments of the right and
left forearms in the i.a. group and right forearm only in the i.v. group. There were no significant differences between compartmental CSA
levels in all tissues examined on the locally treated, right side
during i.a. infusion, indicating that drug streaming from the catheter
tip is not occurring in our model. During i.a. infusion, mean CSA
concentrations were 4- to 7-fold higher in the right limb than in the
left limb in all four tissues examined. Tissue CSA levels in the left
limb were equivalent to those achieved during i.v. infusion, but CSA
concentrations in blood, kidney, and liver were higher during i.a.
infusion. These favorable, preliminary, single-dose pharmacokinetic
results warrant further investigation in our novel rabbit model.
0022-3565/99/2893-1185$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
M. V. Shirbacheh, T. A. Harralson, J. W. Jones, W. C. Breidenbach, A. W. Jevans, C. Maldonado, J. H. Barker, and S. A. Gruber Pharmacokinetic Advantage of Intra-arterial Cyclosporin A Delivery to Vascularly Isolated Rabbit Forelimb. II. Dose Dependence J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1191 - 1195. [Abstract] [Full Text] |
||||
![]() |
M. V. Shirbacheh, J. W. Jones, T. A. Harralson, J. Edelstein, T. Tecimer, W. C. Breidenbach, A. W. Jevans, C. Maldonado, J. H. Barker, and S. A. Gruber Pharmacokinetics of Intra-arterial Delivery of Tacrolimus to Vascularly Isolated Rabbit Forelimb J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1196 - 1201. [Abstract] [Full Text] |
||||